Karachi: Liven Pharma Limited has completed a significant expansion of its paid-up capital following a merger that was sanctioned by the High Court of Sindh. According to the company's official announcements on September 02, 2024, September 24, 2024, and November 07, 2024, this move is part of an approved Scheme of Arrangement aimed at restructuring the company's financial standing.

Before the merger, the paid-up capital of Liven Pharma stood at 12.12 million shares. As a result of the merger, an additional 80.92 million shares were issued in CDS form, bringing the total paid-up capital to 93.04 million shares.

According to information available from the Pakistan Stock Exchange (PSX), this increase in share capital aligns with the company's strategic objectives and fulfills the requirements set out in the merger agreement. The company has requested that the TRE Certificate Holders of the Exchange be informed of these changes.